Cargando…

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review

The need for proven disease-specific treatments for the novel pandemic coronavirus SARS-CoV-2 necessitates a worldwide search for therapeutic options. Since the SARS-CoV-2 virus shares extensive homology with SARS-CoV and MERS-CoV, effective therapies for SARS-CoV and MERS-CoV may also have therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Jennifer, Brierley, Stephanie, Gandhi, Mohit J., Cohen, Michael A., Moschella, Phillip C., Declan, Arwen B. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412090/ https://www.ncbi.nlm.nih.gov/pubmed/32629804 http://dx.doi.org/10.3390/v12070705

Ejemplares similares

Repurposing current therapeutic regimens against SARS-CoV-2 (Review)
por: K. Konstantinidou, Sofia, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

Improved and optimized drug repurposing for the SARS-CoV-2 pandemic
por: Cohen, Sarel, et al.
Publicado: (2023)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
por: Ahsan, Tamim, et al.
Publicado: (2021)

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs
por: Abuo-Rahma, Gamal El-Din A., et al.
Publicado: (2020)

Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase
por: Abidi, Syed Hani, et al.
Publicado: (2021)

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
por: Firestone, Tessa M., et al.
Publicado: (2021)

Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
por: Rampogu, Shailima, et al.
Publicado: (2021)

Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
por: Pandey, Abhjieet, et al.
Publicado: (2020)

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics
por: Piras, Anna Maria, et al.
Publicado: (2020)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
por: Patocka, Jiri, et al.
Publicado: (2021)

Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses
por: Shen, Zhewei, et al.
Publicado: (2022)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022)

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Tackling SARS-CoV-2: proposed targets and repurposed drugs
por: Joshi, Siddhi, et al.
Publicado: (2020)

560. Repurposing Eravacycline for the Treatment of SARS-CoV-2 Infections
por: Reig, Núria, et al.
Publicado: (2020)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Applying polypharmacology approach for drug repurposing for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2022)

Drug repurposing for SARS-CoV-2 (COVID-19) treatment
por: Mtewa, Andrew G., et al.
Publicado: (2022)

Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option
por: Sabarimurugan, Shanthi, et al.
Publicado: (2020)

Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
por: Ray, Abhik Kumar, et al.
Publicado: (2022)

Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity
por: Matos, Aline da Rocha, et al.
Publicado: (2022)

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
por: Deshpande, Rujuta R., et al.
Publicado: (2020)

Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches
por: Mukherjee, Amrita, et al.
Publicado: (2021)

Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies
por: Jamal, Qazi Mohammad Sajid, et al.
Publicado: (2021)

Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection
por: Rosalia, Rina
Publicado: (2021)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

An integrated drug repurposing strategy for the rapid identification of potential SARS-CoV-2 viral inhibitors
por: Trezza, Alfonso, et al.
Publicado: (2020)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
por: Anand, Nithishwer Mouroug, et al.
Publicado: (2021)

Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection
por: Vohra, Manik, et al.
Publicado: (2021)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2
por: Tammam, Salma N., et al.
Publicado: (2021)

Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Programmed ribosomal frameshifting in HIV-1 and the SARS–CoV
por: Brierley, Ian, et al.
Publicado: (2006)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dqmagjqfo676if91prao3taalp